Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-16

Clinical Trial Update: Risk of Recurrent Urethral Stricture After Treatment With Paclitaxel-Coated Dilatation Balloon (Optilume) Compared With Non-coated Dilatation Balloon [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating recurrence risk after urethral dilatation using paclitaxel-coated Optilume balloon versus a non-coated balloon; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Non-Coated Dilatation Balloon Catheter (balloon dilatation catheter (non-coated))
  • Optilume Paclitaxel-Coated Balloon Catheter (paclitaxel-coated balloon catheter)

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Urethral Stricture | Phase 4 | Status: RECRUITING